Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ezban

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Biochemistry|October 3, 1995
Kinetics of the interaction between the human factor VIIIa subunits: effects of pH, ionic strength, Ca2+ concentration, heparin, and activated protein C-catalyzed proteolysisE Persson, M Ezban, R M Shymko
Thrombosis and Haemostasis|December 18, 1987
F VIII subunits: purification and antigenic propertiesO Nordfang, M Ezban, J J Hansen
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 2, 2015
Factor IX-deficient plasma spiked with N9-GP behaves similarly to N9-GP post-administration clinical samples in N9-GP ELISA and FIX activity assaysM H Sørensen, S Andersen, M Ezban
Trends in Cardiovascular Medicine|January 11, 2001
Tissue factor-dependent factor VIIa signalingL C Petersen, P Freskgård, M Ezban
Developments in Biological Standardization|January 1, 1980
Progress in chemical and in vivo characterization of albumin preparationsM Ezban, K Wallevik, J F Hansen
Journal of Thrombosis and Haemostasis : JTH|May 13, 2016
Overestimation of N-glycoPEGylated factor IX activity in a one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IXP Rosén, S Rosén, M Ezban, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosisB Arnljots, T Söderström, M Ezban, et al.
Journal of Thrombosis and Haemostasis : JTH|June 1, 2016
Factor VIII chromogenic assays can be used for potency labeling and postadministration monitoring of N8-GPW Pickering, M Hansen, M Kjalke, et al.
Journal of Thrombosis and Haemostasis : JTH|January 14, 2009
Evaluation of the safety and pharmacokinetics of a fast-acting recombinant FVIIa analogue, NN1731, in healthy male subjectsJ Møss, B Scharling, M Ezban, et al.
British Journal of Haematology|March 1, 1988
Radioimmunoassay for quantitative measurement of factor VIII-heavy chainO Nordfang, M Ezban, P Nilsson, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Biochemistry|October 3, 1995
Kinetics of the interaction between the human factor VIIIa subunits: effects of pH, ionic strength, Ca2+ concentration, heparin, and activated protein C-catalyzed proteolysisE Persson, M Ezban, R M Shymko
Thrombosis and Haemostasis|December 18, 1987
F VIII subunits: purification and antigenic propertiesO Nordfang, M Ezban, J J Hansen
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 2, 2015
Factor IX-deficient plasma spiked with N9-GP behaves similarly to N9-GP post-administration clinical samples in N9-GP ELISA and FIX activity assaysM H Sørensen, S Andersen, M Ezban
Trends in Cardiovascular Medicine|January 11, 2001
Tissue factor-dependent factor VIIa signalingL C Petersen, P Freskgård, M Ezban
Developments in Biological Standardization|January 1, 1980
Progress in chemical and in vivo characterization of albumin preparationsM Ezban, K Wallevik, J F Hansen
Journal of Thrombosis and Haemostasis : JTH|May 13, 2016
Overestimation of N-glycoPEGylated factor IX activity in a one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IXP Rosén, S Rosén, M Ezban, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosisB Arnljots, T Söderström, M Ezban, et al.
Journal of Thrombosis and Haemostasis : JTH|June 1, 2016
Factor VIII chromogenic assays can be used for potency labeling and postadministration monitoring of N8-GPW Pickering, M Hansen, M Kjalke, et al.
Journal of Thrombosis and Haemostasis : JTH|January 14, 2009
Evaluation of the safety and pharmacokinetics of a fast-acting recombinant FVIIa analogue, NN1731, in healthy male subjectsJ Møss, B Scharling, M Ezban, et al.
British Journal of Haematology|March 1, 1988
Radioimmunoassay for quantitative measurement of factor VIII-heavy chainO Nordfang, M Ezban, P Nilsson, et al.
Pageof 9